JAMIE BUMP: Open Payments
NPI 1912250432 · OLNEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 22 payments from 11 companies in 2025. Trend: 2023 $394 · 2024 $307 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $182 |
| Novo Nordisk Inc | 6 | $107 |
| ABBVIE INC. | 3 | $63 |
| Dexcom, Inc. | 1 | $34 |
| Braeburn Inc. | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
Products named: AIRSUPRA, FARXIGA, Dexcom G6 Transmitter, BREZTRI, VRAYLAR, BRIXADI, APTIMA, Wegovy.
Industry payments across IL — which companies pay providers there.
